WO2004073718A1 - 痔疾患用治療剤 - Google Patents

痔疾患用治療剤 Download PDF

Info

Publication number
WO2004073718A1
WO2004073718A1 PCT/JP2004/001701 JP2004001701W WO2004073718A1 WO 2004073718 A1 WO2004073718 A1 WO 2004073718A1 JP 2004001701 W JP2004001701 W JP 2004001701W WO 2004073718 A1 WO2004073718 A1 WO 2004073718A1
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic agent
hemorrhoid
diseases
anal
external
Prior art date
Application number
PCT/JP2004/001701
Other languages
English (en)
French (fr)
Inventor
Yukiko Inamoto
Seiichiro Kawabata
Mitsuhiro Kawada
Original Assignee
Teikoku Seiyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Co., Ltd. filed Critical Teikoku Seiyaku Co., Ltd.
Priority to AU2004212813A priority Critical patent/AU2004212813B2/en
Priority to MXPA05008883A priority patent/MXPA05008883A/es
Priority to US10/545,910 priority patent/US8183232B2/en
Priority to EP04711719A priority patent/EP1609472A4/en
Priority to KR1020057015363A priority patent/KR101167317B1/ko
Priority to CA2515259A priority patent/CA2515259C/en
Priority to NZ541931A priority patent/NZ541931A/en
Priority to CN200480004668A priority patent/CN100594909C/zh
Publication of WO2004073718A1 publication Critical patent/WO2004073718A1/ja
Priority to IL170151A priority patent/IL170151A/en
Priority to NO20054320A priority patent/NO20054320L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

　アセチルサリチル酸またはその薬理学的に許容される塩を有効成分とする痔核（内痔核、外痔核）および裂肛などの痔疾患およびその他の肛門疾患に対する治癒作用、並びに鎮痛、鎮痒作用を併せ持つ肛門疾患の外用治療剤。
PCT/JP2004/001701 2003-02-21 2004-02-17 痔疾患用治療剤 WO2004073718A1 (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AU2004212813A AU2004212813B2 (en) 2003-02-21 2004-02-17 Therapeutic agent for hemorrhoidal disease
MXPA05008883A MXPA05008883A (es) 2003-02-21 2004-02-17 Agente terapeutico para enfermedad hemorroidal.
US10/545,910 US8183232B2 (en) 2003-02-21 2004-02-17 Therapeutic agent for hemorrhoidal disease
EP04711719A EP1609472A4 (en) 2003-02-21 2004-02-17 THERAPEUTIC ACTIVE FOR THE TREATMENT OF HEMORRHOIDAL DISEASES
KR1020057015363A KR101167317B1 (ko) 2003-02-21 2004-02-17 치질환 치료제
CA2515259A CA2515259C (en) 2003-02-21 2004-02-17 Use of acetylsalicylic acid for the treatment of hemorrhoidal disease
NZ541931A NZ541931A (en) 2003-02-21 2004-02-17 Therapeutic agent for hemorrhoidal disease
CN200480004668A CN100594909C (zh) 2003-02-21 2004-02-17 痔疮治疗剂
IL170151A IL170151A (en) 2003-02-21 2005-08-08 Therapeutic cause of hemorrhoids
NO20054320A NO20054320L (no) 2003-02-21 2005-09-20 Terapeutisk middel mot hemoroidesykdom

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003-044384 2003-02-21
JP2003044384A JP4791682B2 (ja) 2003-02-21 2003-02-21 痔疾患用治療剤

Publications (1)

Publication Number Publication Date
WO2004073718A1 true WO2004073718A1 (ja) 2004-09-02

Family

ID=32905450

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2004/001701 WO2004073718A1 (ja) 2003-02-21 2004-02-17 痔疾患用治療剤

Country Status (14)

Country Link
US (1) US8183232B2 (ja)
EP (1) EP1609472A4 (ja)
JP (1) JP4791682B2 (ja)
KR (1) KR101167317B1 (ja)
CN (1) CN100594909C (ja)
AU (1) AU2004212813B2 (ja)
CA (1) CA2515259C (ja)
IL (1) IL170151A (ja)
MX (1) MXPA05008883A (ja)
NO (1) NO20054320L (ja)
NZ (1) NZ541931A (ja)
TW (1) TWI315984B (ja)
WO (1) WO2004073718A1 (ja)
ZA (1) ZA200506286B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100178255A1 (en) * 2009-01-15 2010-07-15 Madhavi Sekharam Kotha Composition and method to treat otitis media and ventilator- associated pneumonia
KR101067443B1 (ko) 2009-06-23 2011-09-27 여오영 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물
WO2013070236A1 (en) * 2011-11-11 2013-05-16 Ventrus Biosciences, Inc. Methods and compositions for treating hemorrhoids while providing local anesthetic and anti-inflammatory effects
JP6992057B2 (ja) 2016-06-10 2022-01-13 クラリティ コスメティックス インコーポレイテッド 非面皰形成性の毛髪および頭皮ケア製剤ならびにその使用方法
EP3834831A1 (en) * 2019-12-12 2021-06-16 Hendrik de Keulenaer Treatment of hemorrhoids with anticoagulant drugs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS635018A (ja) * 1986-06-26 1988-01-11 Kao Corp 坐剤
JPH08245369A (ja) * 1995-03-08 1996-09-24 Tendou Seiyaku Kk 粘膜保護剤
EP1022019A1 (en) * 1997-10-08 2000-07-26 Taisho Pharmaceutical Co., Ltd Suppository composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740420A (en) * 1967-11-28 1973-06-19 Crown Zellerbach Corp Pharmaceutical compositions with dimethyl sulfoxide
US4126681A (en) * 1975-12-08 1978-11-21 The Procter & Gamble Company Topical composition containing acetyl salicylic acid
US4383986A (en) * 1981-08-17 1983-05-17 Ortho Pharmaceutical Corporation Hemorrhoidal compositions
US4613498A (en) * 1984-10-24 1986-09-23 Frank Crosby Hemorrhoid medication
AU1778088A (en) * 1987-03-17 1989-12-21 Mahmood Ali Dr. Khan Use of analgesic anti-inflammatory drugs in treating haemorrhoidal bleeding
US5932230A (en) * 1997-05-20 1999-08-03 Degrate; Frenchell Topical analgesic formulation containing fruits, oils and aspirin
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
JP4729149B2 (ja) * 1997-06-25 2011-07-20 帝國製薬株式会社 安定なアスピリン軟膏製剤
JP2001187739A (ja) * 1999-12-28 2001-07-10 Teikoku Seiyaku Co Ltd アレルギー性皮膚疾患治療用外用剤
HU228233B1 (en) * 1999-12-28 2013-02-28 Teikoku Seiyaku Co Antipruritic agents for external use
WO2002098404A1 (en) * 2001-06-01 2002-12-12 Tendskin Company Topical compositions for veterinary uses
CN1205951C (zh) * 2002-06-10 2005-06-15 王兴泉 一种治疗腋臭和癣类及肛门外痔的药物组合物
US20040062778A1 (en) * 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS635018A (ja) * 1986-06-26 1988-01-11 Kao Corp 坐剤
JPH08245369A (ja) * 1995-03-08 1996-09-24 Tendou Seiyaku Kk 粘膜保護剤
EP1022019A1 (en) * 1997-10-08 2000-07-26 Taisho Pharmaceutical Co., Ltd Suppository composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1609472A4 *

Also Published As

Publication number Publication date
TWI315984B (en) 2009-10-21
AU2004212813B2 (en) 2009-02-26
NO20054320L (no) 2005-11-18
CA2515259A1 (en) 2004-09-02
US8183232B2 (en) 2012-05-22
NO20054320D0 (no) 2005-09-20
IL170151A (en) 2015-04-30
NZ541931A (en) 2010-10-29
JP2004262775A (ja) 2004-09-24
KR101167317B1 (ko) 2012-07-19
MXPA05008883A (es) 2005-10-05
US20060159711A1 (en) 2006-07-20
KR20050102663A (ko) 2005-10-26
EP1609472A4 (en) 2007-10-24
TW200509945A (en) 2005-03-16
AU2004212813A1 (en) 2004-09-02
CN100594909C (zh) 2010-03-24
CA2515259C (en) 2012-09-18
EP1609472A1 (en) 2005-12-28
ZA200506286B (en) 2006-05-31
CN1750831A (zh) 2006-03-22
JP4791682B2 (ja) 2011-10-12

Similar Documents

Publication Publication Date Title
WO2006017505A3 (en) Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
GB9902689D0 (en) Organic compounds
WO2006037031A3 (en) Formulations and methods for treatment of inflammatory diseases
EP1589947B8 (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration
AU2003247616A1 (en) Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis
WO2004037222A3 (en) Sustained-release tramadol formulations with 24-hour efficacy
WO2006033006A3 (en) Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor
GB0211649D0 (en) Organic compounds
RU2008127882A (ru) Лечение пищевода барретта
WO2005005414A3 (en) Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2004071374A3 (en) Once a day orally administered pharmaceutical compositions
BR0013793A (pt) Medicamentos profiláticos e terapêuticos para doenças oftálmicas
WO2004037207A3 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
WO2006064228A3 (en) Thiazolopyramidine compounds for the modulation of chemokine receptor activity
WO2005044187A3 (en) Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
WO2004073718A1 (ja) 痔疾患用治療剤
NO20051261L (no) Morfin-6-glukuronidsalt
EP1741430A4 (en) REMEDY FOR PSYCHO NEUROSIS DISEASES
WO2005097192A3 (en) Active substance combination of a carbinol compound and an opioid
WO2007005763A3 (en) Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer
ATE411053T1 (de) Albuminkonjugate, die eine glucuron-verknüpfung enthalten
WO2008120617A1 (ja) クローン病に伴う腸管狭窄の進展抑制用医薬組成物
WO2006047799A3 (en) Treatment of heart failure with csf-1
CA2370501A1 (en) Pharmaceutical composition for the therapy of lower urinary tract symptoms

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2515259

Country of ref document: CA

Ref document number: 3477/DELNP/2005

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2005/06286

Country of ref document: ZA

Ref document number: 200506286

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 170151

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2004212813

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2006159711

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10545910

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2004711719

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/008883

Country of ref document: MX

Ref document number: 1020057015363

Country of ref document: KR

Ref document number: 541931

Country of ref document: NZ

Ref document number: 20048046688

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2004212813

Country of ref document: AU

Date of ref document: 20040217

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004212813

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1020057015363

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2004711719

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10545910

Country of ref document: US